Start practising

PassthePSA › PSA revision › Adverse drug reactions for the PSA

PSA revision notes

Adverse drug reactions for the PSA

ADR types A and B, timing, classic drug and reaction pairs, finding the culprit drug, anticholinergic burden, Yellow Card reporting and BNF frequencies.

Start practising →Every question free, no card
Short answerAn adverse drug reaction is harm caused by a medicine at normal doses. Type A reactions are dose-related and predictable; type B are idiosyncratic or immune-mediated. To find the culprit, match the timing of onset to recent starts and dose changes, check the known side-effect profile, then dechallenge. Suspected reactions can be reported through the MHRA Yellow Card scheme.

What are type A and type B adverse drug reactions?

Type A reactions are augmented pharmacological effects of the drug, and they are the common ones. Type B reactions are bizarre, not predicted from the pharmacology, and rarer but more often serious.

  • Type A: dose-related, predictable, common, low mortality (hypoglycaemia with insulin, bleeding with warfarin, sedation with opioids).
  • Type B: dose-independent, idiosyncratic or immune-mediated, unpredictable, higher mortality (anaphylaxis, Stevens-Johnson syndrome, DRESS).
  • Type C: long-term use. Type D: delayed effects. Type E: end of use, such as withdrawal. Type F: failure of therapy, often from an interaction.

Timing helps classify the reaction. Anaphylaxis occurs within minutes to hours, DRESS typically 2 to 8 weeks after starting, and cutaneous reactions such as Stevens-Johnson syndrome in the first weeks. Effects of amiodarone can appear months after starting.

Classic drug and adverse reaction pairs

DrugReactionKey point
ACE inhibitorDry cough; angioedema; hyperkalaemiaCough is bradykinin-mediated; switch to an ARB. Angioedema can occur at any time; stop
StatinMyopathy; rhabdomyolysisMuscle pain; check CK; risk with interacting drugs
AmiodaroneThyroid, lung, liver, corneal, skin effectsLong half-life; effects persist after stopping
LithiumTremor, vomiting, confusion, ataxia, seizuresToxicity with dehydration, NSAIDs, ACE inhibitors, thiazides
MetoclopramideAcute dystonia, oculogyric crisisYoung adults and children; short-term use only
SulfonylureasHypoglycaemiaRisk in renal impairment and older people
SGLT2 inhibitorsKetoacidosis, genital infection, volume depletionDKA can occur with near-normal glucose; Fournier gangrene is rare
Flucloxacillin, co-amoxiclavCholestatic jaundiceCan start after the course has finished
FluoroquinolonesTendon rupture, neuropsychiatric effectsStop at first tendon pain; extra risk with corticosteroids
Allopurinol, carbamazepine, lamotrigineSevere skin reactionsEarly rash needs urgent review; lamotrigine needs slow titration
AbacavirHypersensitivityHLA-B*5701 testing before starting
Beta-blockersBradycardia, bronchospasm, masked hypoglycaemiaCaution in asthma and diabetes

How do you decide which drug caused a reaction?

Work back from the onset of the problem to the most recent change in treatment. A new drug or dose increase in the right time window is the leading suspect.

  1. List all drugs with start dates, dose changes and recent interacting additions.
  2. Check whether the reaction fits the known profile of each drug in the BNF.
  3. Check the timing: immediate, within weeks or after months.
  4. Consider other causes, such as infection, disease progression or dehydration.
  5. Dechallenge: stop the suspected drug and see whether the reaction settles.
  6. Rechallenge only when safe, and never after a severe reaction such as angioedema or a severe cutaneous reaction.

In a drug-induced liver injury, stop the suspected drug and look at the pattern of ALT versus ALP. In drug reaction questions, an old stable drug is usually less likely than a recent start, unless an interaction or worsening renal function has raised its level.

What is anticholinergic burden?

Anticholinergic burden is the cumulative effect of several drugs with antimuscarinic activity, and it is a classic cause of confusion and falls in older people. Effects include dry mouth, constipation, urinary retention, blurred vision, tachycardia and delirium.

Common contributors are oxybutynin, tricyclic antidepressants such as amitriptyline, chlorphenamine, procyclidine and some antipsychotics. Review and stop where possible, and avoid starting anticholinergics in older people with dementia.

What is the Yellow Card scheme, and how does the BNF list frequency?

The Yellow Card scheme is the MHRA system for reporting suspected adverse reactions, and healthcare professionals, patients and carers can all report. Report all suspected reactions for black-triangle medicines and vaccines, and serious suspected reactions for established medicines. Proof of causation is not needed.

The BNF lists side-effects by frequency, with very common being 1 in 10 or more, common 1 in 100 to 1 in 10, uncommon 1 in 1000 to 1 in 100, rare 1 in 10 000 to 1 in 1000, very rare fewer than 1 in 10 000, and frequency not known.

Check lists: use the BNF Side-effects section of the monograph, and the MHRA Drug Safety Update for newer warnings. Confirm details in the current BNF.

Check yourself

  • What distinguishes a type A from a type B reaction?
  • Which ACE inhibitor reaction is a reason to avoid the class altogether?
  • What are the early features of lithium toxicity?
  • Which drug causes acute dystonia in young people?
  • Why can SGLT2 inhibitors cause ketoacidosis with a normal glucose?
  • How does flucloxacillin liver injury differ in timing?
  • How do you decide which drug caused a new rash?
  • What can be reported on a Yellow Card?

Questions people ask

What is the difference between type A and type B reactions?

Type A reactions are predictable, dose-related and common. Type B reactions are unpredictable, not dose-related, and rarer but more severe.

Why do ACE inhibitors cause a cough?

They reduce bradykinin breakdown, causing a dry cough. An ARB is the usual alternative for cough. After ACE inhibitor angioedema, avoid the class and use an ARB only with caution and specialist advice.

Who can submit a Yellow Card?

Healthcare professionals, patients and carers can all report suspected adverse reactions to the MHRA. Certainty about causation is not required.

What is anticholinergic burden?

The combined antimuscarinic effects of multiple drugs, causing confusion, constipation, retention and falls, particularly in older people.

How does the BNF describe side-effect frequency?

As very common, common, uncommon, rare, very rare or frequency not known, with defined ranges from 1 in 10 or more down to fewer than 1 in 10 000.

Sources: BNF; MHRA Yellow Card scheme; MHRA Drug Safety Update; NICE guidance. These notes are for exam revision and are not patient-specific advice; in the exam and in practice, the BNF is the authority.

Prefer plain text? Read this page as plain text · All PSA revision notes.

Now practise it under exam conditions

1,200+ questions and 11 full mock papers, marked like the PSA with the BNF open. Every question is free.

Start practising →Read the PSA exam guide
Start practising →